Leukemia Patients Stay In Remission More Than Two Years With New T Cell Therapy

tD33NAt

Active member
Joined
Mar 24, 2008
Messages
12,519
Reaction score
0
Points
36
Leukemia patients who received infusions of their own T cells, after the cells had been genetically engineered to fight the patients' cancerous tumors, reacted to the therapy in a positive way, staying in full remission for over two years. The new therapy was developed by a group of scientists from the Perelman School of Medicine at the University of Pennsylvania and the results will be presented at the American Society of Hematology's Annual Meeting and Exposition...
66K487kRhhI


More...
 
Back
Top